查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566898

体外膜氧合市场：按类型、成分、应用划分：2024-2033 年全球机会分析与产业预测

Extracorporeal Membrane Oxygenation Machine Market By Type , By Components By Application : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年体外膜氧合（ECMO）市值为5.042亿美元，预计2024年至2033年复合年增长率为4.6%，到2033年达到7.937亿美元。

体外膜氧合 (ECMO) 是医疗设备，有助于去除二氧化碳并将富氧血液送回体内。该机器充当生命维持机器，治疗患有心肺功能障碍的患者。 ECMO 的工作原理是透过氧合器（膜氧合器）将血液循环回血流。这个过程为血液充氧并去除二氧化碳，有效地模仿了人类肺和心臟的功能。

体外膜氧合（ECMO）市场的全球成长主要是由心臟衰竭和心源性休克等呼吸系统和心臟疾病疾病盛行率的惊人上升所推动的。英国国家英国估计，约有 660 万人患有心血管或呼吸系统疾病。其中，据报导有 350 万人患有心血管疾病，370 万人患有呼吸道疾病。此外，医疗保健专业人员意识的提高和医疗培训的进步正在导致 ECMO 的广泛使用。根据体外生命支持（ELSO）登记处 2023 年 6 月的评估，2020 年有 151,683 名患者使用了 ECMO。其中，成人 75,735 人，儿童 30,743 人，新生儿 45,205 人。此外，老年人口的快速增加也对市场成长做出了重大贡献。这是因为老年人由于功能障碍而更容易患慢性病和器官衰竭，限制了他们进行日常活动的能力，从而推高了对 ECMO 的需求。根据世界卫生组织（WHO）的数据，2019年60岁以上的人口有10亿人。预计到 2030 年，这一数字将增至 14 亿，到 2050 年将增至 21 亿，这可能会对市场成长做出重大贡献。然而，ECMO系统的初始投资和维护成本，以及缺乏熟练的系统操作人员，正在阻碍市场的成长。此外，许多国家没有足够的医疗保健设施来满足其人口的需求，而有限的医疗服务也是市场的主要阻碍因素。相反，ECMO 技术的不断改进，包括更小、更有效率的系统，以及政府对重症患者医疗基础设施安装和开发的资金和支持的增加，预计将在预测期内扩大市场，从而提供利润丰厚的机会。

体外膜氧合 (ECMO) 市场按类型、组件、应用和区域细分。依类型划分，市场分为静脉-动脉、静脉-静脉和动-静脉。按组件划分，它们分为泵浦、充氧器、控制器等。依用途分为成人、儿童、新生儿。按地区划分，对北美、欧洲、亚太地区和拉丁美洲地区市场进行了分析。

主要发现

按类型划分，预计到 2033 年动静脉设备领域将主导市场。

从组成部分来看，制氧机预计将在预测期内成为主要细分市场。

从应用来看，成人市场预计在未来几年将呈现显着的复合年增长率。

按地区划分，北美是 2023 年的主要收益贡献国家，并且很可能在预测期内主导市场。

可以自订此报告（需要额外的费用和时间表）

  • 监管指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 公司简介的扩充列表
  • 历史市场资料
  • SWOT分析

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 主要投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章体外膜氧合（ECMO）市场：依类型

  • 市场概况
  • 静脉动脉
  • 静脉
  • 其他的

第五章体外供氧（ECMO）市场：依组成部分

  • 市场概况
  • 泵浦
  • 氧气供应
  • 控制器
  • 其他的

第六章 体外供氧（ECMO）市场：依应用分类

  • 市场概况
  • 成人
  • 儿科的
  • 新生

第七章 体外膜氧合（ECMO）市场：依地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国体外膜氧合（ECMO）市场
    • 加拿大体外膜氧合（ECMO）市场
    • 墨西哥体外膜氧合（ECMO）市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国体外膜氧合（ECMO）市场
    • 德国体外膜氧合（ECMO）市场
    • 义大利体外膜氧合（ECMO）市场
    • 西班牙体外膜氧合（ECMO）市场
    • 英国体外膜氧合（ECMO）市场
    • 其他欧洲国家体外膜氧合 (ECMO) 市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国体外膜氧合（ECMO）市场
    • 日本体外膜氧合（ECMO）市场
    • 印度体外膜氧合（ECMO）市场
    • 韩国体外膜氧合（ECMO）市场
    • 澳洲体外膜氧合（ECMO）市场
    • 其他亚太地区体外膜氧合 (ECMO) 市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西体外膜氧合（ECMO）市场
    • 南非体外膜氧合（ECMO）市场
    • 沙乌地阿拉伯体外膜氧合（ECMO）市场
    • 其他拉丁美洲/中东/非洲体外膜氧合 (ECMO) 市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • Medtronic Plc
  • Sorin Group
  • Terumo Corporation
  • MAQUET Holding
  • Nipro Medical Corporation
  • Microport Scientific Corporation
  • Medos Medizintechnik AG
  • GETINGE AB
  • Livanova Plc
  • Fresnius Medical Care
简介目录
Product Code: A284556

The extracorporeal membrane oxygenation machine (ECMO) market was valued at $504.2 million in 2023, and is projected to reach $793.7 million by 2033, growing at a CAGR of 4.6% from 2024 to 2033.

Extracorporeal membrane oxygenation machine (ECMO) is a medical device that assists in removal of carbon dioxide and sends oxygen-rich blood back to the body. The machine serves as a life support system to treat individuals suffering from cardiac and pulmonary dysfunction. ECMO functions by circulating blood through an artificial lung (membrane oxygenator) and back into the bloodstream. This process allows the blood to be oxygenated and carbon dioxide to be removed, effectively mimicking the functions of human lungs and heart.

The growth of the global extracorporeal membrane oxygenation machine (ECMO) market is majorly driven by alarming rise in prevalence of respiratory and cardiac diseases such as heart failure and cardiogenic shock. According to the estimates of the Office of National Statistics, UK, approximately 6.6 million individuals were suffering from either a cardiovascular or respiratory condition. Among these, 3.5 million individuals were reported to have a cardiovascular condition, whereas 3.7 million had a respiratory condition. Moreover, increase in awareness among healthcare providers and advancements in medical training lead have led to a wider adoption of ECMO. Based on the June 2023 assessment by the Extracorporeal Life Support Organization (ELSO) registry, ECMO was used on 151,683 patients in 2020. Among these, 75,735 were adults, 30,743 were children, and 45,205 were neonates. Furthermore, surge in geriatric population notably contributes toward the market growth. . This is attributed to the fact that aged individuals are highly susceptible to chronic diseases and organ failure due to functional impairment that limit the ability to carry out day-to-day chores, thus boosting the demand for ECMO. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050, which is likely to significantly contribute toward the market growth. However, initial investment and maintenance costs of ECMO systems and dearth of skilled personnel to operate the system hamper the growth of the market. Moreover, lack of appropriate health facilities to meet population needs in most countries and limited access act as the key deterrent factors of the market. On the contrary, continuous improvements in ECMO technology, including more compact and efficient systems, and increase in government funding and support to set up & develop critical care infrastructure are expected to offer lucrative opportunities for the expansion of the market during the forecast period.

The extracorporeal membrane oxygenation machine (ECMO) market is segmented into type, component, application, and region. Depending on type, the market is classified into veno-arterial, veno-venous, and arterio-venous. As per component, it is classified into pumps, oxygenator, controllers, and others. On the basis of application, it is segregated into adult, pediatric, and neonates. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By type, the arterio-venous machine segment is expected to dominate the market by 2033.

On the basis of component, oxygenator is anticipated to emerge as a leading segment during the forecast period.

Depending on application, the adult segment is projected to exhibit notable CAGR in the coming years.

Region wise, North America was the major revenue contributor in 2023, and is likely to dominate the market during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global extracorporeal membrane oxygenation machine (ECMO) market include Medtronic Plc, Sorin Group, Terumo Corporation, MAQUET Holding, Nipro Medical Corporation, Microport Scientific Corporation, Medos Medizintechnik AG, GETINGE AB, Livanova Plc., and Fresnius Medical Care. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to gain a strong foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Type

  • Veno-arterial
  • Veno-venous
  • Others

By Components

  • Pumps
  • Oxygenator
  • Controllers
  • Others

By Application

  • Adult
  • Pediatric
  • Neonates

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Medtronic Plc
    • Sorin Group
    • Terumo Corporation
    • MAQUET Holding
    • Nipro Medical Corporation
    • Microport Scientific Corporation
    • Medos Medizintechnik AG
    • GETINGE AB
    • Livanova Plc
    • Fresnius Medical Care

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Veno-arterial
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Veno-venous
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Others
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Components
  • 5.2. Pumps
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Oxygenator
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Controllers
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Application
  • 6.2. Adult
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Pediatric
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Neonates
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Components
    • 7.2.4. Market Size and Forecast, By Application
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Components
      • 7.2.6.3. Market Size and Forecast, By Application
    • 7.2.7. Canada Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Components
      • 7.2.7.3. Market Size and Forecast, By Application
    • 7.2.8. Mexico Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Components
      • 7.2.8.3. Market Size and Forecast, By Application
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Components
    • 7.3.4. Market Size and Forecast, By Application
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Components
      • 7.3.6.3. Market Size and Forecast, By Application
    • 7.3.7. Germany Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Components
      • 7.3.7.3. Market Size and Forecast, By Application
    • 7.3.8. Italy Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Components
      • 7.3.8.3. Market Size and Forecast, By Application
    • 7.3.9. Spain Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Components
      • 7.3.9.3. Market Size and Forecast, By Application
    • 7.3.10. UK Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Components
      • 7.3.10.3. Market Size and Forecast, By Application
    • 7.3.11. Rest of Europe Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Components
      • 7.3.11.3. Market Size and Forecast, By Application
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Components
    • 7.4.4. Market Size and Forecast, By Application
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Components
      • 7.4.6.3. Market Size and Forecast, By Application
    • 7.4.7. Japan Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Components
      • 7.4.7.3. Market Size and Forecast, By Application
    • 7.4.8. India Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Components
      • 7.4.8.3. Market Size and Forecast, By Application
    • 7.4.9. South Korea Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Components
      • 7.4.9.3. Market Size and Forecast, By Application
    • 7.4.10. Australia Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Components
      • 7.4.10.3. Market Size and Forecast, By Application
    • 7.4.11. Rest of Asia-Pacific Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Components
      • 7.4.11.3. Market Size and Forecast, By Application
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Components
    • 7.5.4. Market Size and Forecast, By Application
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Components
      • 7.5.6.3. Market Size and Forecast, By Application
    • 7.5.7. South Africa Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Components
      • 7.5.7.3. Market Size and Forecast, By Application
    • 7.5.8. Saudi Arabia Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Components
      • 7.5.8.3. Market Size and Forecast, By Application
    • 7.5.9. Rest of LAMEA Extracorporeal Membrane Oxygenation Machine (ECMO) Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Components
      • 7.5.9.3. Market Size and Forecast, By Application

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Medtronic Plc
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Sorin Group
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Terumo Corporation
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. MAQUET Holding
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Nipro Medical Corporation
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Microport Scientific Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Medos Medizintechnik AG
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. GETINGE AB
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Livanova Plc
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Fresnius Medical Care
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments